Mysimba® is subject to additional monitoring. To report an adverse event or a product complaint about Mysimba®, please contact: HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517; Website: www.hpra.ie; e-mail: email@example.com Adverse events should also be reported to Orexigen®: 1-800-902-210 or Mysimba@druginfo.com.
For all other queries, please contact our Irish office at Tel: +353 (0)1 2057760, Fax: +353 (0)1 2698919 or firstname.lastname@example.org
Copyright ©2017 Consilient Health. All rights reserved.
The information on this website is intended for healthcare professionals registered in the Republic of Ireland only.
Mysimba® is a registered trademark of Nalpropion Pharmaceuticals LLC
© 2020 Nalpropion Pharmaceuticals LLC